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In the endless drive to get people’s attention, advertising is going ‘native’, creeping in to 
places formerly reserved for editorial content. In this Native Advertising series we find out 
what it looks like, if readers can tell the difference, and more importantly, whether they care. 
 
Academic medical researchers are hot property for companies marketing pharmaceuticals, 
complementary medicines, medical devices, fitness equipment, weight loss products, “health 
foods” and other health-related goods and services. Their opinions are highly respected by the 
general public, and their endorsement in the media of a product can help to ensure consumers 
and patients purchase it, or at least discuss it with their “health care provider”. 
But this raises a question: why would an academic researcher choose to endorse a health-
related product in the general media? 
The most worrying explanation is that the academic is being employed by the company to 
speak favourably about its product. Such commercial relationships are rarely made 
transparent and rely on a public perception that academics are objective observers and 
commentators. For the most part, however, this is unlikely to be the case. 
A far more likely explanation is that any academic endorsement occurs in the context of a 
long and mutually productive relationship with the company concerned. Academics are 
frequently targeted by companies on the grounds that they provide authority and act as “key 
opinion leaders” who are able to influence the opinions, beliefs and behaviours of others in 
both professional and public arenas. 
This relationship with industry is frequently one of many. Academics who comment on 
products have frequently partnered with the company in its clinical trials of the product; put 
his or her name to the resulting academic publications; provided strategic advice on how to 
have the product regulated and perhaps subsidised by the government; or given talks to other 
academics and clinicians about the research (if not the product itself). 
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The veneer of independence 
Academics who act as key opinion leaders generally see themselves as “independent” 
research partners, consultants, educators or commentators, whose work is filtered through 
academic peer review, and who is free to discover, publish and say whatever they wish. 
Unfortunately, however, this is simply not true. There is now a compelling body of research 
showing that even non-pecuniary “entanglements” with industry create “ties that bind” that 
subtly and unconsciously shape opinion leaders’ views of companies and their products. 
Indeed, it is often non-financial entanglements that are the most influential, such as “research 
collaborations” and policy consultancies. The professional reputation, public influence and 
career advancement that stem from being a recognised expert can be just as influential as any 
direct payment for “services.” Such inducements are also potentially more influential than 
any vintage wines, extravagant “educational” dinners, or all-expenses-paid trips to 
conferences. Which is perhaps why the pharmaceutical industry has been willing to self-
regulate and no longer lavishes expensive gifts on doctors and research academics. 
So what does this mean for those on the receiving end of academic commentary in the media? 
Importantly, it does not mean academic opinion leaders should simply be ignored or their 
commentary discounted. Academic opinion leaders are often the most qualified people to 
comment on potentially significant products and services. But it does mean, however, that 
both those who write the news, and those who read it, need to be alert to the complex genesis 
of “expert” opinion. 
For this to be possible, relationships between academics and industry need to be transparent. 
Unfortunately, most universities in Australia do not currently demand public disclosure of all 
such relationships, so journalists and readers cannot always be sure just how entangled a 
particular academic commentator might be. 
Transparency is not enough 
Transparency does not, however, in and of itself, tell the journalist or reader how significant 
any entanglement really is, and whether the academic commentator can or cannot be trusted 
to give an objective view. 
On the one hand, disclosures of commercial relationships could lead to the inappropriate 
exclusion of the academic from public and professional comment. It’s important to note that 
researchers who engage with industry usually do so with the best of intentions and are doing 
exactly what today’s universities expect them to do — which is to innovate, commercialise 
and build income streams through relationships with industry. 
On the other hand, greater transparency could lull all concerned into a false sense of security 
based upon the belief that transparency is all that’s needed to ensure integrity, and that what 
is in the open cannot be wrong or harmful. Sunshine is rarely a sufficient disinfectant. 
Rather than focus solely on transparency, therefore, what is needed is a comprehensive and 
pre-emptive strategy that enables productive and ethically-sound interactions between 
academics and industry, while at the same time proscribing the kinds of interactions that are 
likely to lead to bias and adverse social outcomes. 
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Developing and instituting these strategies is the job of academics, professional groups and 
governments — not journalists, and certainly not news consumers, who should be able to rely 
on academic commentators to give an accurate, informed and balanced and disinterested view 
of any health-related product. 
 
 
